Jackson Financial (JXN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
4 Jun, 2026Program overview and structure
Funding Agreement-Backed Notes (FABN) program authorized up to $15 billion, with $7.4 billion outstanding as of March 31, 2026.
Issuer is Jackson National Life Global Funding, backed by Jackson National Life Insurance Company.
Notes are listed on Euronext Dublin, offered in multiple currencies and maturities up to 20 years.
Expected ratings: Moody's A3, S&P A, Fitch A, all with stable outlooks.
$33.5 billion cumulative FABN issuance since 1999.
Business segments and product diversification
Focus on retail annuity products: variable annuities, registered index-linked annuities (RILA), and fixed/fixed index annuities.
Institutional products include GICs, funding agreements, and medium-term notes.
Strategic expansion has increased sales diversification, with a shift from primarily VA sales in 2021 to a more balanced mix by 2025.
Inforce book shows a more diversified balance sheet and earnings stream by 1Q26.
Financial performance and capital position
Strong adjusted operating earnings driven by higher spread income and AUM growth in RILA, fixed index annuities, and institutional products.
Robust capital position: total adjusted capital of $5.5 billion and RBC ratio of 554% as of March 31, 2026.
$342 million capital generated and $325 million dividends/distributions to parent in 1Q26.
Holding company liquidity of nearly $650 million, above targeted minimum buffer.
Latest events from Jackson Financial
- Strong sales, capital returns, and RILA growth position the firm for sustainable expansion.JXN
Investor presentation8 May 2026 - Retail annuity sales rose 31% and $257M was returned to shareholders despite a $435M net loss.JXN
Q1 20266 May 2026 - Record annuity sales and strong capital returns set the stage for higher 2026 shareholder payouts.JXN
Q4 202521 Apr 2026 - TPG partnership and Hickory Re launch drive capital-efficient growth and higher returns.JXN
Partnership20 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification for 2026.JXN
Proxy filing7 Apr 2026 - Exceeded 2025 targets, boosted capital returns, and advanced governance and ESG priorities.JXN
Proxy filing7 Apr 2026 - Q2 2024 saw adjusted operating earnings up 45% and record RILA sales with strong capital returns.JXN
Q2 20242 Feb 2026 - Retail annuity sales hit record highs, but net income turned negative on reinsurance losses.JXN
Q3 202415 Jan 2026 - Record annuity sales, earnings, and capital returns drive strong 2024 results and 2025 outlook.JXN
Q4 20248 Dec 2025